<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30088852</article-id>
<article-id pub-id-type="pmc">6325645</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.40382</article-id>
<article-id pub-id-type="manuscript">NIHMS997231</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A COMPREHENSIVE CLINICAL AND GENETIC STUDY IN 127 PATIENTS WITH ID IN
KINSHASA, DR CONGO</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lumaka</surname>
<given-names>Aimé</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Race</surname>
<given-names>Valerie</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peeters</surname>
<given-names>Hilde</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corveleyn</surname>
<given-names>Anniek</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coban-Akdemir</surname>
<given-names>Zeynep</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jhangiani</surname>
<given-names>Shalini N.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiaofei</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mubungu</surname>
<given-names>Gerrye</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Posey</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lupski</surname>
<given-names>James R</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vermeesch</surname>
<given-names>Joris R</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lukusa</surname>
<given-names>Prosper</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Devriendt</surname>
<given-names>Koenraad</given-names>
</name>
<role>Professor</role>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="corresp" rid="CR1">10</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1.</label>Centre for Human Genetics, Faculty of Medicine, University
of Kinshasa, DR Congo</aff>
<aff id="A2"><label>2.</label>Département des sciences biomédicales et
précliniques, GIGA-R, Laboratoire de Génétique Humaine,
University of Liège, Belgium</aff>
<aff id="A3"><label>3.</label>Institut National de Recherche Biomédicale,
Kinshasa, DR Congo</aff>
<aff id="A4"><label>4.</label>Department of Pediatrics, Faculty of Medicine, University
of Kinshasa, DR Congo</aff>
<aff id="A5"><label>5.</label>Centre for Human Genetics, University Hospital, University
of Leuven, Belgium</aff>
<aff id="A6"><label>6.</label>Department of Molecular and Human Genetics, Baylor College
of Medicine, Houston, TX, 77030, USA.</aff>
<aff id="A7"><label>7.</label>Human Genome Sequencing Center, Baylor College of
Medicine, Houston, TX, 77030, USA</aff>
<aff id="A8"><label>8.</label>Department of Pediatrics, Baylor College of Medicine,
Houston, TX, 77030, USA.</aff>
<aff id="A9"><label>9.</label>Texas Children’s Hospital, Houston, TX, 77030,
USA</aff>
<author-notes>
<corresp id="CR1"><label>10.</label>Corresponding author: Professor Koenraad
Devriendt, MD, PhD, Centre for Human Genetics, University Hospitals, University
of Leuven, Herestraat 49, Bus 602, 3000 Leuven, Belgium.,
<email>koenraad.devriendt@uzleuven.be</email>, Tel.: +32 16 34 59 03, Fax:
+32 16 34 60 60</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P43">CONFLICTS-OF-INTEREST</p>
<p id="P44">J.R.L. has stock ownership in 23andMe, is a paid consultant for
Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., and is a
co-inventor on multiple United States and European patents related to molecular
diagnostics for inherited neuropathies, eye diseases, and bacterial genomic
fingerprinting. The Department of Molecular and Human Genetics at Baylor College
of Medicine derives revenue from molecular genetic testing offered in the
Baylor-Genetics Laboratories.</p>
<p id="P45">The other authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>9</issue>
<fpage>1897</fpage>
<lpage>1909</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.40382-->
<abstract id="ABS1">
<p id="P1">Pathogenic variants account for 4 to 41 % of patients with intellectual
disability (ID) or developmental delay (DD). In Sub-Saharan Africa, the
prevalence of ID is thought to be higher, but data in Central Africa are limited
to some case reports. In addition, clinical descriptions of some syndromes are
not available for this population. This study aimed at providing an estimate for
the fraction of ID/DD for which an underlying etiological genetic cause may be
elucidated and provide insights into their clinical presentation in special
institutions in a Central African country.</p>
<p id="P2">A total of 127 patients (33 females and 94 males, mean age 10.03 ±
4.68 years), were recruited from 6 institutions across Kinshasa. A clinical
diagnosis was achieved in 44 but molecular confirmation was achieved in 21 of
the 22 patients with expected genetic defect (95% clinical sensitivity).
Identified diseases included Down syndrome (15%), submicroscopic copy number
variants (9%), aminoacylase deficiency (0.8%), Partington syndrome in one
patient (0.8%) and his similarly affected brother, X-linked syndromic Mental
Retardation type 33 (0.8%), and two conditions without clear underlying
molecular genetic etiologies (Oculo-Auriculo-Vertebral and Amniotic Bands
Sequence).</p>
<p id="P3">We have shown that genetic etiologies, similar to those reported in
Caucasian subjects, are a common etiologic cause of ID in African patients from
Africa. We have confirmed the diagnostic utility of clinical characterization
prior to genetic testing. Finally, our clinical descriptions provide insights
into the presentation of these genetic diseases in African patients.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>